levodopa/benserazide 100mg/25mg capsules
central procurement & supplies unit - benserazide; levodopa - hard capsule - benserazide 25 mg; levodopa 100 mg - anti-parkinson drugs
madopar roche 125 capsule
roche (malaysia) sdn. bhd. - benserazide hydrochloride; levodopa -
madopar
roche products (nz) ltd - benserazide hydrochloride 50mg; ; levodopa 200mg; - tablet - 250 mg - active: benserazide hydrochloride 50mg levodopa 200mg
madopar dispersible
roche products (nz) ltd - benserazide hydrochloride 25mg; ; ; levodopa 100mg; - dispersible tablet - 125 mg - active: benserazide hydrochloride 25mg levodopa 100mg excipient: citric acid magnesium stearate maize starch microcrystalline cellulose
madopar 100/25 milligram tablets
roche products limited - levodopa, benserazide hydrochloride - tablets - 100/25 milligram - dopa and dopa derivatives
madopar 50/12.5 milligram tablets
roche products limited - levodopa, benserazide hydrochloride - tablets - 50/12.5 milligram - dopa and dopa derivatives
madopar capsule (200/50)
roche products pty ltd - levodopa, quantity: 200 mg; benserazide hydrochloride, quantity: 57 mg (equivalent: benserazide, qty 50 mg) - capsule, hard - excipient ingredients: iron oxide yellow; magnesium stearate; indigo carmine; povidone; gelatin; titanium dioxide; purified talc; microcrystalline cellulose; iron oxide red - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.
madopar rapid 125 dispersible 125mg tablet bottle
roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - tablet, dispersible - excipient ingredients: citric acid; microcrystalline cellulose; magnesium stearate; pregelatinised maize starch - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.
madopar 125 capsule bottle
roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - capsule, hard - excipient ingredients: indigo carmine; purified talc; gelatin; iron oxide red; magnesium stearate; povidone; microcrystalline cellulose; titanium dioxide - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.
madopar 62.5 capsule bottle
roche products pty ltd - levodopa, quantity: 50 mg; benserazide hydrochloride, quantity: 14.25 mg (equivalent: benserazide, qty 12.5 mg) - capsule, hard - excipient ingredients: indigo carmine; iron oxide black; magnesium stearate; microcrystalline cellulose; purified talc; titanium dioxide; povidone; mannitol; gelatin - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.